Additionally, four genes, i.e., CA9, EGLN3, BHLHE41, and VWF, had an AUC >0.8 based on the ROC analysis, indicating that their expression may serve as a very good classifier for the life expectancy of patients with ccRCC. This evidence concerns the gene BHLHE41 and nonpapillary renal cell carcinoma.